BIOHARVEST SCIENCES INC. logo

BIOHARVEST SCIENCES INC.

0001723464

BioHarvest is a pioneer in botanical synthesis, developing and manufacturing patentable plant-based molecules. Their proprietary Botanical Synthesis process enables innovative BIOLOGICS+ compositions for the pharmaceutical and nutraceutical industries. They've also launched a CDMO unit to address industry needs.

90
Altamente Confiable
Puntuación de Confianza

Registro Oficial

Número de IVA
000000000
Dirección
1140 - 625 HOWE STREET, VANCOUVER, A1 V6C 2T6
Códigos de Industria
Pharmaceutical Preparations, 2834

Análisis de Calidad IA

Industria
Biotechnology
SSL/HTTPS
Seguro
Correo profesional
Correo de contacto
hello@vinia.com

🌟 Empresas similares de confianza

Context Therapeutics Inc.

Context Therapeutics Inc. logo
86/100 · Altamente Confiable

Context Therapeutics is dedicated to advancing the treatment of solid tumors through the development of next-generation T cell engaging (TCE) bispecific antibody therapies. Their innovative pipeline features clinical-stage bispecific therapeutics designed to harness the immune system for targeted cancer eradication. The company focuses on innovative immunotherapeutic solutions, transforming cancer care and improving outcomes for patients.

2001 MARKET STREET, Estados Unidos
Ver perfil

AGENUS INC

AGENUS INC logo
86/100 · Altamente Confiable

Agenus is a biotechnology company focused on developing and commercializing immuno-oncology therapies. Their key products include botensilimab and balstilimab, which are in clinical trials for various cancers. The company is positioned as an innovator in the development of next-generation immunotherapies.

3 FORBES ROAD, Estados Unidos
Ver perfil

Evaxion A/S

Evaxion A/S logo
77/100 · Confiable

Evaxion utilizes its AI-Immunology™ platform to challenge and improve standardized treatments. In oncology, they create personalized therapies, tailoring treatment to the individual. For infectious diseases, they design next-generation vaccines to address unmet medical needs. Their AI platform accelerates vaccine target discovery, design, and development.

DR NEERGAARDS VEJ 5F, Estados Unidos
Ver perfil